C
TransMedics Group, Inc. TMDX
$120.55 $1.581.33% NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
EPS (TTM)

06/30/2025 03/31/2025 12/31/2024 09/30/2024 06/30/2024
Revenue 157.37M 143.54M 121.62M 108.76M 114.31M
Total Other Revenue -- -- -- -- --
Total Revenue 157.37M 143.54M 121.62M 108.76M 114.31M
Cost of Revenue 60.78M 55.31M 49.61M 47.92M 45.04M
Gross Profit 96.59M 88.23M 72.01M 60.85M 69.26M
SG&A Expenses 44.09M 43.63M 46.91M 42.66M 42.90M
Depreciation & Amortization -- -- -- -- --
Other Operating Expenses -- -- -- -- --
Total Operating Expenses 120.80M 116.09M 112.98M 104.84M 101.80M
Operating Income 36.57M 27.44M 8.64M 3.92M 12.51M
Income Before Tax 36.18M 26.68M 6.99M 4.25M 12.15M
Income Tax Expenses 1.28M 994.00K 132.00K 29.00K -41.00K
Earnings from Continuing Operations 34.91M 25.68M 6.86M 4.22M 12.19M
Earnings from Discontinued Operations -- -- -- -- --
Extraordinary Item & Accounting Change -- -- -- -- --
Minority Interest in Earnings -- -- -- -- --
Net Income 34.91M 25.68M 6.86M 4.22M 12.19M
EBIT 36.57M 27.44M 8.64M 3.92M 12.51M
EBITDA 43.30M 33.58M 14.32M 9.10M 17.11M
EPS Basic 1.03 0.76 0.20 0.13 0.37
Normalized Basic EPS 0.67 0.49 0.13 0.08 0.23
EPS Diluted 0.92 0.70 0.20 0.12 0.35
Normalized Diluted EPS 0.56 0.42 0.12 0.07 0.22
Average Basic Shares Outstanding 33.91M 33.72M 33.59M 33.44M 33.12M
Average Diluted Shares Outstanding 40.56M 39.91M 35.21M 35.68M 35.29M
Dividend Per Share -- -- -- -- --
Payout Ratio -- -- -- -- --